Preeclampsia has an association with both platelet count and mean platelet volume: A systematic review and

Muluken Walle1, Yemataw Gelaw2, Fasil Getu1

  • 1Medicallaboratory Science Department, College of Medicine and Health Sciences, Jigjiga University, Jigjiga, Ethiopia.

Plos One
|September 14, 2022
PubMed

Insights

Preeclampsia (PE) is linked to lower platelet counts (PC) and higher mean platelet volume (MPV) in pregnant women. These hematological changes may signal the development of PE.

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Perinatology

Background:

  • Preeclampsia (PE) is a pregnancy-specific disorder.
  • Endothelial dysfunction and coagulation system activation characterize PE.
  • Altered platelet parameters are common hematological findings in PE.

Purpose of the Study:

  • To systematically review global studies on the relationship between platelet count (PC) and PE.
  • To investigate the association between mean platelet volume (MPV) and PE.
  • To calculate the pooled weighted mean difference (WMD) of PC and MPV between PE and normotensive (NT) groups.

Main Methods:

  • Systematic search of PubMed, Web of Science, and African journals (Jan 2011-Jan 2021).
  • Grey literature search via Google Scholar and Google.
  • Random-effects model meta-analysis to estimate pooled WMD of platelet parameters.

Main Results:

  • 25 articles were included; 23 used for PC and MPV analyses.
  • Pooled WMD showed a significant decrease in PC (-41.45 × 10^9/L) in PE vs. NT.
  • Pooled WMD revealed a significant increase in MPV (0.98 fl) in PE vs. NT.

Conclusions:

  • This meta-analysis confirms a significant decrease in PC and a significant increase in MPV in pregnant women with PE.
  • Changes in PC and MPV may serve as indicators for PE development.
Abstract

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
617
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.4K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.0K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
32